$134 Million Verdict in Nevada HRT Case Reduced by $100 million
October 11, 2007
RENO, Nev. - A Nevada jury has reduced its compensatory damages verdict by $100 million for three women awarded $134 million last week on claims they developed breast cancer allegedly caused by Wyeth's Prempro and Premarin hormone replacement drugs. McCreary, et al. v. Wyeth Pharmaceuticals, et al., No. CV04-01699 (Nev. Dist. Ct., Washoe Cty. ).
The Washoe County District Court jury altered the award Oct. 12 after it was determined that they had considered punitive damages in the initial phase of the verdict, which was handed up Oct. 10 and was to include only compensatory damages suffered by the three …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach